Novel dosage formulation

Details for Australian Patent Application No. 2006298898 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Page, Susanne; Ahmed, Hashim A.; Shah, Navnit Hargovindas

Agent Spruson & Ferguson

Pub. Number AU-B-2006298898 (Modified Examination)

PCT Pub. Number WO2007/039420

Priority 60/719,793 23.09.05 US

Filing date 13 September 2006

Wipo publication date 12 April 2007

Acceptance publication date 30 June 2011

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039420 Priority application(s): WO2007/039420

30 June 2011 Application Accepted

  Published as AU-B-2006298898 (Modified Examination)

27 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006298902-D-amino acid a selectable marker for barley (Hordeum vulgare L.) transformation

2006298895-Pharmaceutical preparation containing meloxicam